Biblio print

Tree Display

AceDB Schema

XML Display


Paper(s) concerning Galanthamine

38 reference(s) found.
Listing paper details in reverse chronological order.
We are grateful to Keith Bradnam for improvment of this script

    Title: Chemical Survey of Three Species of the Genus Rauhia Traub (Amaryllidaceae)
    Tallini LR, Osorio EH, Berkov S, Torras-Claveria L, Rodriguez-Escobar ML, Viladomat F, Meerow AW, Bastida J
    Ref: Plants (Basel), 11:, 2022 : PubMed


    Title: Loss of Basal Forebrain Cholinergic Neurons Following Adolescent Binge Ethanol Exposure: Recovery With the Cholinesterase Inhibitor Galantamine
    Crews FT, Fisher R, Deason C, Vetreno RP
    Ref: Front Behavioral Neuroscience, 15:652494, 2021 : PubMed


    Title: Gigantelline, gigantellinine and gigancrinine, cherylline- and crinine-type alkaloids isolated from Crinum jagus with anti-acetylcholinesterase activity
    Ka S, Masi M, Merindol N, Di Lecce R, Plourde MB, Seck M, Gorecki M, Pescitelli G, Desgagne-Penix I, Evidente A
    Ref: Phytochemistry, 175:112390, 2020 : PubMed


    Title: Cholinesterase-inhibitory effect and in silico analysis of alkaloids from bulbs of Hieronymiella species
    Ortiz JE, Garro A, Pigni NB, Aguero MB, Roitman G, Slanis A, Enriz RD, Feresin GE, Bastida J, Tapia A
    Ref: Phytomedicine, 39:66, 2018 : PubMed


    Title: Cooperative hydrogen bonds and mobility of the non-aromatic ring as selectivity determinants for human acetylcholinesterase to similar anti-Alzheimer's galantaminics: a computational study
    Rocha REO, Lima LHF
    Ref: J Biomol Struct Dyn, :1, 2018 : PubMed


    Title: Post-Injury Administration of Galantamine Reduces Traumatic Brain Injury Pathology and Improves Outcome
    Zhao J, Hylin MJ, Kobori N, Hood KN, Moore AN, Dash PK
    Ref: Journal of Neurotrauma, 35:362, 2018 : PubMed


    Title: Alkaloids from Habranthus tubispathus and H. jamesonii, two amaryllidaceae with acetyl- and butyrylcholinesterase inhibition activity
    Cavallaro V, Alza NP, Murray MG, Murray AP
    Ref: Nat Prod Commun, 9:159, 2014 : PubMed


    Title: GC-MS of amaryllidaceous galanthamine-type alkaloids
    Berkov S, Viladomat F, Codina C, Suarez S, Ravelo A, Bastida J
    Ref: J Mass Spectrom, 47:1065, 2012 : PubMed


    Title: Rapid TLC/GC-MS identification of acetylcholinesterase inhibitors in alkaloid extracts
    Berkov S, Bastida J, Nikolova M, Viladomat F, Codina C
    Ref: Phytochem Anal, 19:411, 2008 : PubMed


    Title: The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design
    Greenblatt HM, Guillou C, Guenard D, Argaman A, Botti SA, Badet B, Thal C, Silman I, Sussman JL
    Ref: Journal of the American Chemical Society, 126:15405, 2004 : PubMed


    Title: Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts
    Lopez S, Bastida J, Viladomat F, Codina C
    Ref: Life Sciences, 71:2521, 2002 : PubMed


    Title: Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs
    Bartolucci C, Perola E, Pilger C, Fels G, Lamba D
    Ref: Proteins, 42:182, 2001 : PubMed


    Title: Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts
    Guillou C, Mary A, Renko DZ, Gras E, Thal C
    Ref: Bioorganic & Medicinal Chemistry Lett, 10:637, 2000 : PubMed


    Title: The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6
    Bachus R, Bickel U, Thomsen T, Roots I, Kewitz H
    Ref: Pharmacogenetics, 9:661, 1999 : PubMed


    Title: Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington
    Davis KL
    Ref: Geriatrics, 54:42, 1999 : PubMed


    Title: Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution
    Greenblatt HM, Kryger G, Lewis T, Silman I, Sussman JL
    Ref: FEBS Letters, 463:321, 1999 : PubMed


    Title: Effect of the acetylcholinesterase inhibitor galanthamine on learning and memory in prolonged alcohol intake rat model of acetylcholine deficit
    Iliev A, Traykov V, Prodanov D, Mantchev G, Yakimova K, Krushkov I, Boyadjieva N
    Ref: Methods Find Exp Clin Pharmacol, 21:297, 1999 : PubMed


    Title: Capillary zone electrophoresis determination of galanthamine in biological fluids and pharmaceutical preparatives: experimental design and artificial neural network optimization
    Pokorna L, Revilla A, Havel J, Patocka J
    Ref: Electrophoresis, 20:1993, 1999 : PubMed


    Title: Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications
    Giacobini E
    Ref: Neurochem Int, 32:413, 1998 : PubMed


    Title: Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series
    Mary A, Renko DZ, Guillou C, Thal C
    Ref: Bioorganic & Medicinal Chemistry, 6:1835, 1998 : PubMed


    Title: Evaluation of four Narcissus cultivars as potential sources for galanthamine production [letter]
    Moraes-Cerdeira RM, Burandt CL, Jr., Bastos JK, Nanayakkara D, Mikell J, Thurn J, McChesney JD
    Ref: Planta Med, 63:472, 1997 : PubMed


    Title: Pharmacological basis of drug therapy of Alzheimer's disease
    Sharma A, Parikh V, Singh M
    Ref: Indian J Exp Biol, 35:1146, 1997 : PubMed


    Title: Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine
    Bores GM, Huger FP, Petko W, Mutlib AE, Camacho F, Rush DK, Selk DE, Wolf V, Kosley RW, Jr. and Vargas HM <1 more author(s)>
    Ref: Journal of Pharmacology & Experimental Therapeutics, 277:728, 1996 : PubMed


    Title: Galanthamine. [Review] [23 refs]
    Fulton B, Benfield P
    Ref: Drugs & Aging, 9:60, 1996 : PubMed


    Title: [The comparative clinico-experimental characteristics of aminostigmine and galanthamine used for treating poisonings by choline-blocking substances]. [Russian]
    Prozorovskii VB, Velikova VD, Pshenkina NN, Vasilenko ET
    Ref: Eksperimentalnaia i Klinicheskaia Farmakologiia, 59:64, 1996 : PubMed


    Title: The pharmacology of galanthamine and its analogues
    Harvey AL
    Ref: Pharmacol Ther, 68:113, 1995 : PubMed


    Title: Effect of the cholinesterase-inhibiting substance galanthamine on evoked visual potentials in rats
    Lewandowski MH, Zmuda L
    Ref: Acta Neurobiologiae Experimentalis, 55:141, 1995 : PubMed


    Title: Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells
    Storch A, Schrattenholz A, Cooper JC, Abdel Ghani EM, Gutbrod O, Weber KH, Reinhardt S, Lobron C, Hermsen B and Maelicke A <4 more author(s)>
    Ref: European Journal of Pharmacology, 290:207, 1995 : PubMed


    Title: [Aminostigmine as a cholinesterase inhibitor and as an agent for treating poisonings by cholinergic blockers]. [Russian]
    Prozorovskii VB, Livanov GA, Velikova VD, Afanas'ev VV, Pavlova LV
    Ref: Eksperimentalnaia i Klinicheskaia Farmakologiia, 57:13, 1994 : PubMed


    Title: Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine
    Thomsen T, Kaden B, Fischer JP, Bickel U, Barz H, Gusztony G, Cervos-Navarro J, Kewitz H
    Ref: European Journal of Clinical Chemistry & Clinical Biochemistry, 29:487, 1991 : PubMed


    Title: [Catalytic properties of cholinesterases immobilized in a gelatin membrane]
    Kuznetsova LP, Kugusheva LI, Nikol'skaia EB
    Ref: Ukr Biokhim Zh, 62:42, 1990 : PubMed


    Title: Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo
    Thomsen T, Kewitz H
    Ref: Life Sciences, 46:1553, 1990 : PubMed


    Title: Pharmacokinetics of galanthamine (a long-acting anticholinesterase drug) in anaesthetized patients
    Westra P, van Thiel MJ, Vermeer GA, Soeterbroek AM, Scaf AH, Claessens HA
    Ref: British Journal of Anaesthesia, 58:1303, 1986 : PubMed


    Title: [Miniature currents of the endplates of the muscle fibers of the diaphragm of the rat after inhibition of acetylcholinesterase with galanthamine]
    Krivoi II, Kuleshov VI, Matiushkin DP, Sanotskii VI, Sei TP
    Ref: Neirofiziologiia, 17:607, 1985 : PubMed


    Title: [Characteristics of galanthamine as a reversible inhibitor of cholinesterase]
    Vasilenko ET, Tonkopii VD
    Ref: Biokhimiia, 39:701, 1974 : PubMed


    Title: Studies on the synthesis of heterocyclic compounds. CCCXV. Modified total synthesis of (plus or minus)-galanthamine through phenol oxidation
    Kametani T, Yamaki K, Yagi H, Fukumoto K
    Ref: J Chem Soc Perkin 1, 18:2602, 1969 : PubMed


    Title: Galanthamine chemistry. VII. Synthesis of analogues of galanthamine
    Uyeo S, Shirai H, Koshiro A, Yashiro T, Kagei K
    Ref: Chem Pharm Bull (Tokyo), 14:1033, 1966 : PubMed


    Title: [Influence exerted by galanthamine on the acetylcholinesterase activity of various regions of the brain]
    Nesterenko LN
    Ref: Farmakologiia i Toksikologiia, 28:413, 1965 : PubMed


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page

Acknowledgements and disclaimer